Search research articles
Contact Us
Filters
Showing results (211-220 of 369) with videos related to
Page
of 37
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1993
Cytokine regulation of iron metabolism: effect of low-dose interleukin-2 subcutaneous therapy on ferritin, transferrin and iron blood concentrations in cancer patients
P Lissoni, M Cazzaniga, A Ardizzoia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1996
Is there a role for melatonin in the treatment of neoplastic cachexia?
P Lissoni, F Paolorossi, G Tancini, et al.
Tumori
|
August 31, 1993
Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapy
P Lissoni, S Barni, G Tancini, et al.
Tumori
|
June 30, 1991
Mitoxantrone as a single agent in pretreated metastatic breast cancer: effects on T lymphocyte subsets and their relation to clinical response
S Barni, P Lissoni, F Paolorossi, et al.
Tumori
|
August 31, 1994
Lymphocytosis decline is not responsible for tumor progression in cancer patients chronically treated with interleukin-2
P Lissoni, S Barni, M Andres, et al.
Journal of Pineal Research
|
May 8, 1999
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study
P Lissoni, G Tancini, F Paolorossi, et al.
Tumori
|
June 30, 1989
A radiologic study by CT scan of pineal size in cancer patients: correlation to melatonin blood levels
M Tagliabue, P Lissoni, S Barni, et al.
Biological Chemistry Hoppe-Seyler
|
December 1, 1992
Modulation of macrophage response to interleukin-2 immunotherapy by interleukin-3 in cancer patients
P Lissoni, F Rovelli, S Barni, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
March 11, 2004
Gilbert's syndrome and fluorouracil toxicity in colorectal cancer patients: which correlation?
M Mandalà, M Cremonesi, M Cazzaniga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 37
Search research articles
Search
Showing results (211-220 of 369) with videos related to
Sort By:
Page
of 37
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1993
Cytokine regulation of iron metabolism: effect of low-dose interleukin-2 subcutaneous therapy on ferritin, transferrin and iron blood concentrations in cancer patients
P Lissoni, M Cazzaniga, A Ardizzoia, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 1, 1996
Is there a role for melatonin in the treatment of neoplastic cachexia?
P Lissoni, F Paolorossi, G Tancini, et al.
Tumori
|
August 31, 1993
Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapy
P Lissoni, S Barni, G Tancini, et al.
Tumori
|
June 30, 1991
Mitoxantrone as a single agent in pretreated metastatic breast cancer: effects on T lymphocyte subsets and their relation to clinical response
S Barni, P Lissoni, F Paolorossi, et al.
Tumori
|
August 31, 1994
Lymphocytosis decline is not responsible for tumor progression in cancer patients chronically treated with interleukin-2
P Lissoni, S Barni, M Andres, et al.
Journal of Pineal Research
|
May 8, 1999
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study
P Lissoni, G Tancini, F Paolorossi, et al.
Tumori
|
June 30, 1989
A radiologic study by CT scan of pineal size in cancer patients: correlation to melatonin blood levels
M Tagliabue, P Lissoni, S Barni, et al.
Biological Chemistry Hoppe-Seyler
|
December 1, 1992
Modulation of macrophage response to interleukin-2 immunotherapy by interleukin-3 in cancer patients
P Lissoni, F Rovelli, S Barni, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
March 11, 2004
Gilbert's syndrome and fluorouracil toxicity in colorectal cancer patients: which correlation?
M Mandalà, M Cremonesi, M Cazzaniga, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Second line therapy with low-dose subcutaneous interleukin-2 alone in advanced renal cancer patients resistant to interferon-alpha
P Lissoni, S Barni, A Ardizzoia, et al.
Page
of 37